Grant aids drug discovery for autism, schizophrenia
Grant aids drug discovery for autism, schizophrenia
With the aid of a four-year, $2.7 million grant from the National Institute of Mental Health, part of the National Institutes of Health (NIH), Vanderbilt University Medical Center pharmacologist Jerod Denton, PhD, and his team will pave the way for potential treatments for schizophrenia and autism spectrum disorder (ASD).